Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Change in Account Payables (2020)

Insight Molecular Diagnostics (IMDX) has disclosed Change in Account Payables for 1 consecutive years, with -$6000.0 as the latest value for Q1 2020.

  • Quarterly Change in Account Payables changed N/A to -$6000.0 in Q1 2020 from the year-ago period, while the trailing twelve-month figure was -$6000.0 through Dec 2020, changed N/A year-over-year, with the annual reading at -$6000.0 for FY2020, 99.71% up from the prior year.
  • Change in Account Payables hit -$6000.0 in Q1 2020 for Insight Molecular Diagnostics.
  • In the past five years, Change in Account Payables ranged from a high of -$6000.0 in Q1 2020 to a low of -$6000.0 in Q1 2020.